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Objective: The objective of this research was to evaluate the inﬂuence of autologous mono-
nuclear stem cells injections on histological changes of collagen in the ﬁbrous annulus of
the  intervertebral disk after experimental injury.
Methods: 32 New Zealand rabbits were submitted to intervertebral disk puncture, followed
by  intradiscal injection of mononuclear cells from the iliac crest versus saline injection in
the  following time periods: two months after the injury (SC2M and SS2M), two weeks (SC2W
and SS2W) immediately after injury (SCCP and SSCP), and without inducing degeneration
(SCSP and SSSP). Two months after cell therapy, the animals were euthanized and collagen
changes in the intervertebral discs were histologically evaluated.
Results: There were signiﬁcant differences in ELAF between SS2W and SS2S groups
(p  = 0.018). This difference was due to an increase in type I collagen in SS2W group (56.7%)
compared to SC2S (13.28%).
Conclusion: Treatment with mononuclear mesenchymal stem cells reduced changes in the
type I and III collagen distribution in rabbits AF degenerated discs up to two  weeks after the
induction of degeneration. Brasileira de Ortopedia e Traumatologia. Published by Elsevier Editora© 2016 SociedadeLtda. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
 Study conducted at the Service of Orthopedy and Traumatology, Hospital Universitário Cajuru, Pontifícia Universidade Católica do
araná,  Curitiba, PR, Brazil.
∗ Corresponding author.
E-mail: evialle@hotmail.com (E.N. Vialle).
ttp://dx.doi.org/10.1016/j.rboe.2016.10.003
255-4971/© 2016 Sociedade Brasileira de Ortopedia e Traumatologia. Published by Elsevier Editora Ltda. This is an open access article
nder  the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Inﬂuência  da  terapia  celular  mononuclear  sobre  a  degenerac¸ão discal  em
coelhos
Palavras-chave:
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Objetivo: Avaliar a inﬂuência da injec¸ão de células-tronco mononucleares autólogas sobre
as  alterac¸ões histológicas do colágeno no ânulo ﬁbroso do disco intervertebral após lesão
experimental.
Métodos: Foram submetidos 32 coelhos New Zealand a punc¸ão do discos intervertebrais
lombares seguida de injec¸ão intradiscal de células mononucleares provenientes da crista
ilíaca versus injec¸ão de soluc¸ão salina nos seguintes períodos tempo: dois meses após a lesão
(CT2M e SS2M), duas semanas (CT2S e SS2S), imediatamente após a lesão (CTCP e SSCP) e
sem induzir a degenerac¸ão (CTSP e SSSP). Após dois meses da terapia celular, os animais
foram submetidos a eutanásia e as alterac¸ões do colágeno nos discos intervertebrais foram
avaliadas histologicamente.
Resultados: Houve diferenc¸a estatisticamente signiﬁcativa na CEAF entre os grupos CT2S
e  SS2S (p = 0,018). Essa diferenc¸a decorreu de um aumento do colágeno do tipo I no grupo
SS2S (56,7%) comparado com o CT2S (13,28%).
Conclusão: O tratamento com células mononucleares precursoras mesenquimais é capaz de
reduzir as alterac¸ões na distribuic¸ão do colágeno do tipo I e III no AF de discos degenerados
de  coelhos até duas semanas após a induc¸ão da degenerac¸ão.
©  2016 Sociedade Brasileira de Ortopedia e Traumatologia. Publicado por Elsevier
Editora Ltda. Este e´ um artigo Open Access sob uma licenc¸a CC BY-NC-ND (http://Introduction
Disk degeneration is part of the aging process and comprises
the loss of structural, biological, and biochemical properties of
the intervertebral disk (IVD).1 It is characterized by the produc-
tion of dysfunctional cells and a decrease of the intracellular
components, leading to gradual loss of intradiscal ﬂuid.2 This
causes disk dehydration, which entails a cascade of factors
that can lead to symptoms and functional limitation. The
main symptom of disk degeneration is low back pain.3
The etiology of disk degeneration is multifactorial; both
constitutional and environmental factors play roles with
varying degrees of importance.4 Physical exertion, poor pos-
ture, obesity, professional occupation, smoking, alcohol, and
diabetes are involved in the etiology of symptomatic disk
degeneration.5
Low back pain is the second leading cause of medical
consultation in the United States. Worldwide, approximately
60–80% of people will experience low back pain during their
lifetime. According to US data, 20 billion dollars per year are
spent on direct costs for the treatment of chronic low back
pain; added to the indirect costs, this amount exceeds $100
billion.6,7
In order to alleviate this alarming picture, several therapeu-
tic strategies have been attempted, ranging from non-invasive
modalities – such as anti-inﬂammatory medication and phys-
iotherapy – to surgical procedures such as vertebral fusion,
intradiscal electrothermal therapy, and total disk replace-
ment. However, current therapeutic methods are directed
toward the treatment of the symptoms, not the interruption
of and/or recovery from the degenerative process.8 Various
biological treatment models have been proposed as options
for the application of the new technologies. The use of cellcreativecommons.org/licenses/by-nc-nd/4.0/).
elements proposes a direct involvement in the modulation
of the degenerative process, through the introduction of cells
that are potentially able to reconstruct the damaged tissue.9
Based on an animal model previously studied and validated
in this educational institution,10 this study aimed to evaluate
the inﬂuence of injection of autologous mononuclear cells on
histological collagen changes in the annulus ﬁbrosus (AF) of
the IVD after experimental injury.
Material  and  methods
The experiments in this study were made in accordance
with the rules and ethical principles set forth by the Brazil-
ian College of Animal Experimentation (Colégio Brasileiro de
Experimentac¸ão Animal [COBEA]). The methods were based
on previous studies conducted in this institution,10–12 as well
as on the studies by Lipson and Muir,13 Masuda et al.,14 and
Rousseau et al.15
This study was approved by the Ethics Committee on Ani-
mal  Use of the Pontifícia Universidade Católica do Paraná
under No. 377 and was implemented in accordance with the
rules of the Helsinki Declaration of the World Medical Associ-
ation.
Male, white New Zealand rabbits (Oryctolagus cuniculus),
weighing between 2.5 and 3 kg and aged approximately 8
months were used.
After standard anesthesia (10–12), rabbits were placed in
the lateral position and submitted to a lumbotomy with expo-
sure of the lumbar spine through the retroperitoneal access
route (Fig. 1), which exposed the anterior surface of ﬁve
consecutive lumbar IVDs (L2-L3 to L6-L7). The three experi-
mental discs were punctured with a 40 mm × 12 mm (18 G 1½)
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Fig. 1 – Surgical preparation.
Anesthetized rabbits were  placed in right lateral decubitus
position; the posterolateral retroperitoneal access route
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eedle at a depth of 5 mm,  which remained inside the IVD for
 s (Fig. 2).
The process of isolation and collection of mononuclear
tem cells (SC) was done by puncture-aspiration of bone mar-
ow from the iliac crest, and is part of the protocol that has
lready been developed and consolidated in this educational
nstitution.16
After cells were collected and isolated, they were
ntroduced into the animal IVD with the same surgical tech-
ique as described above. The material was placed in the
pper limit of the pre-drilled IVD, with a smaller-caliber needle
13 × 4.5; 26 G ½). Exactly analogous procedures were per-
ormed in animals that received only isotonic saline solution
SS); the amount injected was equal to the cell volume, follow-
ng the abovementioned conditions.
The study included 32 animals, divided into eight groups:
our groups that received SC and four control groups that
eceived SS.
The groups were divided according to the moment of SC
njection:
 SC2M (four animals): transplantation of autologous mono-
nuclear SCs after two months of disk degeneration
induction surgery; SC2W (four animals): transplantation of autologous mono-
nuclear SCs after two weeks of disk degeneration induction
surgery;
ig. 2 – Needle preparation to perform the puncture.
he ﬁnal 5 mm of a 40 mm × 12 mm (18 G1 ½) needle was
elimited from its bevel and folded in an S-shape in order
o standardize the depth of the punctures.;5 1(6):707–715 709
- SCCP (four animals): transplantation of autologous mono-
nuclear stem cells immediately after the disk degeneration
induction surgery.
This differentiation allowed for a periodic comparative
critical analysis regarding the most appropriate period of
implementation of cell therapy in light of the degenerative
process.
- SCSP (four animals), the group that received mononuclear
stem cells, but did not undergo disk degeneration induction
surgery.
Similarly, the animals that were part of the control group
were subdivided according to the pairing with respect to the
experimental group and received isotonic SS injection, as fol-
lows: SS2M (four animals), corresponding to SC2M; SS2W (four
animals), corresponding to SC2W; SSCP (four animals), corre-
sponding to SCCP; and SSSP (four animals), corresponding to
SCSP.
Of the 32 rabbits, six died during surgery or postoperatively.
Thus, 26 rabbits were histologically examined, divided accord-
ing to Tables 1 and 2.
Eight weeks after the injection (CS/SS) in the IVD, the
rabbits were euthanized by injection of an overdose of pen-
tobarbital (90 mg/kg) and their spines were harvested for
histological analysis.
After the samples were processed, dehydrated, and embed-
ded in parafﬁn, sections of 6 micron thickness were taken.
The sections were stained with sirius red for collagen analy-
sis. Through a microscope with polarized light, aspects related
to the collagen arrangement in the IVDs were observed with
20-fold magniﬁcation.
From each slide prepared with an IVD, six ﬁelds of vision
were photographed by the software DinoCapture® 2.0 v.1.2.7
(AnMo Electronics Corporation). The six ﬁelds had been pre-
deﬁned for all discs, starting from the most peripheral layer of
the AF lamellae (Fig. 3). This convention allows for a panoramic
and comprehensive sample of the AF structure.
The images were processed by the software Image  Pro Plus®
v.4.50 (Media Cybernetics, Silver Spring, MD), which quantiﬁed
the green (collagen type III)  and red dots (collagen type III)  of
the slide, and stratiﬁed them with their respective percentages
(Fig. 4).
Results
In order to compare groups and ﬁnd possible signiﬁcant differ-
ences between them, the following variables were individually
assessed: the inner layer of the AF (ILAF); the external layer of
the AF (ELAF); and the entire AF.
For each variable and each type of collagen, in each appli-
cation time, the null hypothesis that the collagen results in the
SC group would be equal to those of the SS group was tested.
Tables 3–5 shows the descriptive statistics and p-values of the
statistical tests.
When comparing the ILAF of the group injected with SC
with that of the groups injected with SS, no statistically sig-
niﬁcant difference was observed between the groups (Table 3).
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Table 1 – Distribution of rabbits in groups injected with stem cells.
Group Stem cells
SC2M SC2W SCCP SCSP
Rabbits (n = 14) 4  3 4 3
Discs – intervention(n  = 37) 12 9 7 9
Discs – control (n = 60) 16 14 16 14
SC2M, SC injection 2 months after puncture; SC2W, SC injection 2 weeks after puncture; SCCP, SC injection at the same time of puncture; SCSP,
SC injection without puncture.
Table 2 – Distribution of rabbits in groups injected with saline solution.
Group Saline
SS2M SS2W SSCP SSSP
Rabbits (n = 12) 3 2 4 3
Discs – intervention(n  = 35) 9 6 12 8
Discs – control (n = 55) 15 10 17 13
tion SS2M, saline injection 2 months after puncture; SS2W, saline injec
puncture; SSSP, saline injection without puncture.
When comparing the ELAF of the group injected with SC
with that of the groups injected with SS, a statistically signif-
icant difference was observed between the SC2W and SS2W
groups (p = 0.018). This difference was due to an increase in
type I collagen in SS2W group (56.7%) when compared with
SC2S (13.28%). Collagen type I and III values and group com-
parisons are shown in Table 4 and Fig. 5.
Control
Fig. 3 – DinoCapture Tool.
Schematic illustration of the six ﬁelds photographed in a control
from the outer portion and one from the inner portion of the ann
from the outer portion and one from the inner portion of the ann
the disk, one from the outer portion and one from the inner port
external layer of the annulus ﬁbrosus (ELAF) denoting type III, an
annulus ﬁbrosus (ILAF), which indicates type I collagen.2 weeks after puncture; SSCP, saline injection at the same time of
When comparing the AF of the group injected with SC with
that of the groups injected with SS, a statistically signiﬁcant
difference was observed between the SC2W and SS2W groups
(p = 0.025). Once again, this difference was due to an increase
in type I collagen in SS2W group (76.1%) when compared with
the SC2W (53.32%). Collagen type I and III values and group
comparisons are shown in Table 5.
 disk. Two ﬁelds on the lateral right angle of the disk, one
ulus; two ﬁelds on the lateral left angle of the disk, one
ulus; and two ﬁelds on the center of the convex portion of
ion of the annulus. Note the predominance of green in the
d the predominance of red in the internal layer of the
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ELAFILAF
Fig. 4 – Image Pro Plus Tool.
Example of the software used to make the pixel count on a photograph of the inner layer of the annulus ﬁbrosus (ILAF) and
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lhe external layer of the annulus ﬁbrosus (ELAF). Three piece
, percentage of objects in the image; and 3, percentage of th
iscussion
isk degeneration induction has been studied in depth in
nother branch of this research through slides stained in
ematoxylin-eosin, fast green, and sirius red.10 The present
tudy used slides obtained from the same species and popu-
ation of rabbits, and the induction of disk degeneration was
Table 3 – Comparison between groups injected with stem cells 
Variable Col Group n Mean Minim
ILAF I SC2M 12 73.37 2.
SS2M 9 85.5 42.
III SC2M 12 26.63 1.
SS2M 9 14.5 2.
I SC2W 9 93.36 88.
SS2W 6 95.6 87.
III SC2W 9 6.64 1.
SS2W 6 4.4 0.
I SCCP 7 96.61 92.
SSCP 12 96.9 90.
III SCCP 7 3.39 0.
SSCP 12 3.1 0.
I SCSP 9 91.16 78.
SSSP 8 94.8 85.
III SCSP 9 8.84 1.
SSSP 8 5.2 1.
There was no statistically signiﬁcant difference between groups.
Col, collagen; SC2M, SC injection 2 months after puncture; SC2W, SC injec
puncture; SCSP, SC injection without puncture; SS2M, SS injection 2 mont
SS injection at the same time of puncture; SSSP, SS injection without punc
a Nonparametric Kruskal–Wallis test; p < 0.05. information are given for each image: 1, number of objects;
tal image area.
performed in the same manner. The standardization of disk
degeneration induction in rabbits in this experiment, through
the needle puncture method, was effective and was repro-
duced in a similar manner to the results of other studies that
used the same technique.10,17–20
Many contemporary studies used immunohistochemistry
to assess different types of collagen.1,21–23 The forerunners in
or saline regarding ILAF.
um Maximum Standard deviation p-Valuea
39 98.65 29.18 0.286
5 97.5 18.2
35 97.61 29.18 0.286
5 57.5 18.2
93 98.33 3.28 0.157
7 99.6 4.2
67 11.7 3.28 0.157
4 12.3 4.2
56 99.56 2.40 0.800
4 99.4 2.8
44 7.44 2.40 0.800
6 9.6 2.8
9 98.52 6.7 0.149
9 98.7 4.4
48 21.91 6.7 0.149
3 14.1 4.4
tion 2 weeks after puncture; SCCP, SC injection at the same time of
hs after puncture; SS2W, SS injection 2 weeks after puncture; SSCP,
ture.
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Table 4 – Comparison between groups injected with stem cells or saline regarding ELAF.
Variable Col Group n Mean Minimum Maximum Standard deviation p-Valuea
ELAF I SC2M 12 25.85 1.24 68.87 19.58 0.201
SS2M 9 39.2 13.1 82.8 21.0
III SC2M 12 74.15 31.13 98.76 19.58 0.201
SS2M 9 60.8 17.2 86.9 21.0
I SC2W 9 13.28 2.72 20.99 6.55 0.18
SS2W 6 56.7 8.7 98.7 32.8
III SC2W 9 86.72 79.1 97.28 6.55 0.18
SS2W 6 43.3 1.3 91.3 32.8
I SCCP 7 14.91 6.38 29.11 8.16 0.63
SSCP 12 9.1 1.6 21.9 6.9
III SCCP 7 85.9 70.89 93.62 8.16 0.63
SSCP 12 90.9 78.1 98.5 6.9
I SCSP 9 12.5 2.29 36.52 10.54 0.773
SSSP 8 15.0 3.1 60.6 19.7
III SCSP 9 87.95 63.48 97.71 10.54 0.773
SSSP 8 85.0 39.4 96.9 19.7
A statistically signiﬁcant difference was observed between the SC2W and SS2W groups (p = 0.018).
Col, collagen; SC2M, SC injection 2 months after puncture; SC2W, SC injection 2 weeks after puncture; SCCP, SC injection at the same time of
puncture; SCSP, SC injection without puncture; SS2M, SS injection 2 months after puncture; SS2W, SS injection 2 weeks after puncture; SSCP,
 puncSS injection at the same time of puncture; SSSP, SS injection without
a Nonparametric Kruskal–Wallis test; p < 0.05.
this area date back to the late 1990s.1,21 This assessment has as
a main advantage its speciﬁcity; however, it is still an expen-
sive method in Brazil. In the present study, sirius red proved
to be a simple and inexpensive method to assess type I and III
collagen.
Regarding the number of cells injected into the treatment,
current studies are not standardized. Some suggest that cell
culture is essential to the success of treatment; however, most
studies do not discuss considerations for optimal cell number.
Serigano et al.22 indicated that the optimum dose of autolo-
gous mesenchymal stem cells (MSCs) in dogs is 1 × 106 cells.
Table 5 – Comparison between groups injected with stem cells 
Variable Col Group n Mean Min
Entire
AF
I SC2M  12 49.61 2.
SS2M 9 62.3 27.
III SC2M 12 50.39 21.
SS2M 9 37.7 11.
I SC2W 9 53.32 47.
SS2W 6 76.1 48.
III SC2W 9 46,68 40.
SS2W 6 23.9 2.
I SCCP 7 55.76 51.
SSCP 12 53.0 48.
III SCCP 7 44.24 35.
SSCP 12 47.0 39.
I SCSP 9 51.61 43.
SSSP 8 54.9 45.
III SCSP 9 48.39 35.
SSSP 8 45.1 20.
A statistically signiﬁcant difference was observed between the SC2W and 
Col, collagen; SC2M, SC injection 2 months after puncture; SC2W, SC injec
puncture; SCSP, SC injection without puncture; SS2M, SS injection 2 mon
SS injection at the same time of puncture; SSSP, SS injection without punc
a Nonparametric Kruskal-Wallis test; p < 0.05.ture.
In turn, Ghosh et al.23 suggested that a lower dose of 0.1 × 106
may be more  effective. According to the authors, an exagger-
ated number of cells in this environment with low nutrient
supply may cause cells to compete for the supplement, which
may be destructive to the NP due to the accumulation of dead
cells and cellular degradation products.23
Furthermore, the discogenic differentiation of MSCs may
also be stimulated by co-culture. MSCs can be directly culti-
vated in contact with IVD cells. During the co-culture of bone
marrow-derived MSC  and NP cells, it has been observed that
they communicate in a bidirectional manner, which results
or saline regarding AF.
imum Maximum Standard deviation p-Valuea
16 78.59 22.21 0.155
8 88.9 16.1
41 97.84 22.21 0.155
1 72.2 16.1
90 59.15 3.62 0.25
2 97.4 17.5
85 52.10 3.62 0.25
6 51.8 17.5
10 64.33 4.57 0.151
6 60.7 3.5
67 48.90 4.57 0.151
3 51.4 3.5
83 64.43 6.59 0.534
5 79.5 11.1
57 56.17 6.59 0.564
5 54.5 11.1
SS2W groups (p = 0.025).
tion 2 weeks after puncture; SCCP, SC injection at the same time of
ths after puncture; SS2W, SS injection 2 weeks after puncture; SSCP,
ture.
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Fig. 5 – Comparison of percentage of collagen distribution in the external layer of annulus ﬁbrosus (ELAF) between different
groups injected with stem cells and saline.
A statistically signiﬁcant difference was observed between the SC2W and SS2W groups (p = 0.018). Col 1, type 1 collagen; Col
3, type 3 collagen; SC2M, SC injection 2 months after puncture; SC2W, SC injection 2 weeks after puncture; SCCP, SC
injection at the same time of puncture; SCSP, SC injection without puncture. SS2M, saline injection 2 months after puncture;
SS2W, saline injection 2 weeks after puncture; SSCP, saline injection at the same time of puncture; SSSP, saline injection
without puncture.
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sn an improvement in the phenotype of the NP cells and the
ifferentiation of MSC  cells.24 This suggests that the implanta-
ion of MSCs can exert paracrine effects in degenerate NP cells
hat reside on the disk, and help restore normal cell function
nd the disk repair process.
In the present study, mononuclear stem cells were used.
he fact that they are obtained through a simpler process
han the MSC  was taken into account, as they only need to
ndergo two processes of centrifugation and Ficoll-Hypaque
ensity gradient, while the MSC  need to undergo these same
rocesses, in addition to culture and cell growth for approx-
mately 14–16 days, thus presenting higher costs and greater
isk of contamination.16
Injection of MSCs and mononuclear mesenchymal stem
ells is typically safe, although there is a potential for for-
ation of peripheral osteophytes, suggesting the importance
f a proper and safe carrier to inject cells in this region.25
n this regard, the carrier may allow the cell to receive axial
oads, which are important to stimulate the synthesis of
xtracellular matrix and induce MSC  differentiation without
urther exogenous stimulus.26 Different carriers have been
sed in the literature, such as some hydrogels26,27 and ﬁbrin
lue.28Although these studies advocate the use of a mobile
arrier in the application of stem cells, the literature is con-
roversial in this regard. Other studies have used only SS29 or
ven no carrier.22 In the present study, DMEM culture medium
ith 20% fetal bovine serum was used, a method that has also
een used successfully in the literature.30
In the analysis of the present results, when assessing the
ntire AF, a difference between the groups that were injected
wo months after the puncture was observed. The SC2M
howed a slight increase in type III collagen, divided into49.61% type I and 50.39% type III.  The SS2M showed 62.35%
type I and 37.65% type III collagen. The group that received
SC had a division closer to that of the groups in which disk
degeneration was not induced, while the SS group showed a
signiﬁcant increase in the proportion of type I collagen. This
disproportionality occurred in ELAF, indicating a disorgani-
zation of the AF structure. However, the difference was not
statistically signiﬁcant.
The same increase in collagen type I in ELAF and AF could
also be observed between the groups injected two weeks after
the puncture. The SC2W showed 53.32% type I and 46.68% type
III collagen. The SS2W showed 76.15% type I and 23.85% type
IIIcollagen. Once again, it was observed that the group that
received SC had a division closer to that of the groups in which
disk degeneration was not induced, while the SS group had a
signiﬁcant increase in the proportion of type I collagen, again
at the expense of ELAF. In the statistical analysis, a statistically
signiﬁcant difference was observed both in ELAF (p = 0.018) as
well as in AF (p = 0.025).
The present data suggest that mononuclear SC therapy was
able to reshape the changes caused by the injury from the
biopsy needle when the SC are injected after two weeks, but
the same success was not achieved when SCs were injected
two months after injury. Despite the fact that the data from
SC2M was closer to the groups in which disk degeneration
was not induced than were the values from the SC2W, this
difference was not statistically signiﬁcant.
However, when comparing the groups that were injected
at the moment of puncture, SCCP showed 55.76% type I and
44.24% type III collagen. In turn, SSCP showed 53% type I
and 47% type III collagen. This is the highest mismatch in
the results, as it was expected that the SSCP would present
p . 2 0 
r
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2714  r e v b r a s o r t o 
degeneration, with a change in the proportion of type I and
type III collagen after puncture. This suggests that the damage
caused in the discs of SSCP were healed.
When comparing the groups that were injected without
puncture, the SCSP showed 51.61% type I and 48.39% type III
collagen. In turn, the SSSP showed 54.9% type I and 45.10% type
III collagen. As expected, no large differences were observed
between these groups, as degeneration through puncture
was not induced. No statistically signiﬁcant difference was
observed between groups. These data indicate that MSCs did
not alter the structure of collagen in discs that were injected
without degeneration.
Conclusion
Treatment with mononuclear mesenchymal stem cells is able
to reduce changes in the distribution of type I and III collagen
in the AF of degenerated rabbits discs until two weeks after
degeneration induction.
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